Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCMSCs in Ischemic Heart Disease
NCT02666391Phase 2Unknown
- Sponsor
- South China Institute for Stem Cell Biology and Regenerative Medicine
- Start
- May 2016
- Primary completion
- Dec 2017
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in ischemic cardiomyopathy (ICM), myocardial infarction (MI), sponsored by South China Institute for Stem Cell Biology and Regenerative Medicine. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
ischemic cardiomyopathy (ICM)myocardial infarction (MI)
Beyond the preview
Go deeper on NCT02666391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02666391.